Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.

Abdulfatah E, Wakeling E, Sakr S, Al-Obaidy K, Bandyopadhyay S, Morris R, Feldman G, Ali-Fehmi R.

Gynecol Oncol. 2019 Sep;154(3):467-474. doi: 10.1016/j.ygyno.2019.06.012. Epub 2019 Jun 24.

PMID:
31248668
2.

Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.

Abdulfatah E, Lordello L, Khurram M, Van de Vijver K, Alosh B, Bandyopadhyay S, Oliva E, Ali-Fehmi R.

Int J Gynecol Pathol. 2019 May;38(3):205-215. doi: 10.1097/PGP.0000000000000497.

PMID:
30958427
3.

Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular Septal Defect (VSD).

Radhakrishna U, Albayrak S, Zafra R, Baraa A, Vishweswaraiah S, Veerappa AM, Mahishi D, Saiyed N, Mishra NK, Guda C, Ali-Fehmi R, Bahado-Singh RO.

PLoS One. 2019 Mar 21;14(3):e0200229. doi: 10.1371/journal.pone.0200229. eCollection 2019.

4.

The use of 3'-deoxy-3'-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy.

Ueberroth BE, Lawhorn-Crews JM, Heilbrun LK, Smith DW, Akoury J, Ali-Fehmi R, Eiseler NT, Shields AF.

Ann Nucl Med. 2019 Jun;33(6):383-393. doi: 10.1007/s12149-019-01345-w. Epub 2019 Feb 27.

PMID:
30810980
5.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S93-S113. doi: 10.1097/PGP.0000000000000524.

6.

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

Malpica A, Euscher ED, Hecht JL, Ali-Fehmi R, Quick CM, Singh N, Horn LC, Alvarado-Cabrero I, Matias-Guiu X, Hirschowitz L, Duggan M, Ordi J, Parkash V, Mikami Y, Ruhul Quddus M, Zaino R, Staebler A, Zaloudek C, McCluggage WG, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S9-S24. doi: 10.1097/PGP.0000000000000552.

7.

A Simplified Risk Stratification Method for Women With Stage I Endometrial Carcinoma.

Elshaikh MA, Modh A, Sakr S, Shrestha R, Burmeister C, Ali-Fehmi R, Hanna RK.

Am J Clin Oncol. 2019 Feb;42(2):131-137. doi: 10.1097/COC.0000000000000484.

PMID:
30260801
8.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Shaik AN, Ruterbusch JJ, Abdulfatah E, Shrestha R, Daaboul MHDF, Pardeshi V, Visscher DW, Bandyopadhyay S, Ali-Fehmi R, Cote ML.

Breast Cancer Res. 2018 Aug 9;20(1):91. doi: 10.1186/s13058-018-1027-6.

9.

Gynecologic Cancers: Molecular Updates 2018.

Abdulfatah E, Ahmed Q, Alosh B, Bandyopadhyay S, Bluth MH, Ali-Fehmi R.

Clin Lab Med. 2018 Jun;38(2):421-438. doi: 10.1016/j.cll.2018.02.007. Review.

PMID:
29776639
10.

Breast Carcinoma: Updates in Molecular Profiling 2018.

Bandyopadhyay S, Bluth MH, Ali-Fehmi R.

Clin Lab Med. 2018 Jun;38(2):401-420. doi: 10.1016/j.cll.2018.02.006. Review.

PMID:
29776638
11.

Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.

Guastella AR, Michelhaugh SK, Klinger NV, Fadel HA, Kiousis S, Ali-Fehmi R, Kupsky WJ, Juhász C, Mittal S.

J Neurooncol. 2018 Sep;139(2):239-249. doi: 10.1007/s11060-018-2869-6. Epub 2018 Apr 17.

12.

Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multiinstitutional Study.

Abdulfatah E, Lordello L, Khurram M, Van de Vijver K, Alosh B, Bandyopadhyay S, Oliva E, Ali-Fehmi R.

Int J Gynecol Pathol. 2018 Apr 3. doi: 10.1097/PGP.0000000000000497. [Epub ahead of print]

PMID:
29620586
13.

Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases.

Abdulfatah E, Sakr S, Thomas S, Al-Wahab Z, Mutch DG, Dowdy S, Bandyopadhyay S, Munkarah A, Elshaikh M, Morris R, Ali-Fehmi R.

Int J Gynecol Cancer. 2017 Oct;27(8):1714-1721. doi: 10.1097/IGC.0000000000001050.

14.

HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer.

Jung YS, Najy AJ, Huang W, Sethi S, Snyder M, Sakr W, Dyson G, Hüttemann M, Lee I, Ali-Fehmi R, Franceschi S, Struijk L, Kim HE, Kato I, Kim HC.

Oncotarget. 2017 May 16;8(31):51530-51541. doi: 10.18632/oncotarget.17887. eCollection 2017 Aug 1.

15.

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Saglam O, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman LD, Sood AK, Gershenson DM.

J Surg Oncol. 2018 Feb;117(2):236-244. doi: 10.1002/jso.24801. Epub 2017 Aug 8.

16.

Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.

Sakr S, Abdulfatah E, Thomas S, Al-Wahab Z, Beydoun R, Morris R, Ali-Fehmi R, Bandyopadhyay S.

Int J Gynecol Pathol. 2017 May;36(3):240-252. doi: 10.1097/PGP.0000000000000325.

17.

The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.

Mahdi Z, Abdulfatah E, Pardeshi V, Hassan O, Schultz D, Morris R, Cote ML, Elshaikh MA, Bandyopadhyay S, Ali-Fehmi R.

Int J Gynecol Pathol. 2017 Sep;36(5):405-411. doi: 10.1097/PGP.0000000000000355.

PMID:
28277313
18.

Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer.

Hijaz M, Chhina J, Mert I, Taylor M, Dar S, Al-Wahab Z, Ali-Fehmi R, Buekers T, Munkarah AR, Rattan R.

Gynecol Oncol. 2016 Aug;142(2):323-31. doi: 10.1016/j.ygyno.2016.06.005. Epub 2016 Jun 16.

PMID:
27282964
19.

Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.

Thomas S, Hussein Y, Bandyopadhyay S, Cote M, Hassan O, Abdulfatah E, Alosh B, Guan H, Soslow RA, Ali-Fehmi R.

Arch Pathol Lab Med. 2016 Aug;140(8):836-43. doi: 10.5858/arpa.2015-0220-OA. Epub 2016 May 3.

20.

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.

Wu SY, Rupaimoole R, Shen F, Pradeep S, Pecot CV, Ivan C, Nagaraja AS, Gharpure KM, Pham E, Hatakeyama H, McGuire MH, Haemmerle M, Vidal-Anaya V, Olsen C, Rodriguez-Aguayo C, Filant J, Ehsanipour EA, Herbrich SM, Maiti SN, Huang L, Kim JH, Zhang X, Han HD, Armaiz-Pena GN, Seviour EG, Tucker S, Zhang M, Yang D, Cooper LJ, Ali-Fehmi R, Bar-Eli M, Lee JS, Ram PT, Baggerly KA, Lopez-Berestein G, Hung MC, Sood AK.

Nat Commun. 2016 Apr 4;7:11169. doi: 10.1038/ncomms11169.

21.

New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.

Roma AA, Mistretta TA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R, Barbuto D, Rutgers JK, Silva EG.

Gynecol Oncol. 2016 Apr;141(1):36-42. doi: 10.1016/j.ygyno.2016.02.028.

22.

Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.

Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A.

Cancer Res. 2016 Mar 15;76(6):1391-402. doi: 10.1158/0008-5472.CAN-15-1793. Epub 2016 Feb 2.

23.

Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis.

Wu RL, Ali S, Bandyopadhyay S, Alosh B, Hayek K, Daaboul MF, Winer I, Sarkar FH, Ali-Fehmi R.

J Cancer Sci Ther. 2015;7(7):258-265.

24.

Can problematic fibroepithelial lesions be accurately classified on core needle biopsies?

Bandyopadhyay S, Barak S, Hayek K, Thomas S, Saeed H, Beydoun R, Shi D, Arabi H, Ruterbusch J, Cote M, Ali-Fehmi R.

Hum Pathol. 2016 Jan;47(1):38-44. doi: 10.1016/j.humpath.2015.09.001. Epub 2015 Sep 21.

PMID:
26521710
25.

The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1407-15. doi: 10.1158/1055-9965.EPI-15-0316. Epub 2015 Aug 19.

26.

Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma.

Roma AA, Rybicki LA, Barbuto D, Euscher E, Djordjevic B, Frauenhoffer E, Kim I, Hong SR, Montiel D, Ali-Fehmi R, Malpica A, Silva EG.

Hum Pathol. 2015 Oct;46(10):1529-39. doi: 10.1016/j.humpath.2015.06.015. Epub 2015 Jun 30.

PMID:
26264257
27.

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.

Bollig-Fischer A, Michelhaugh SK, Wijesinghe P, Dyson G, Kruger A, Palanisamy N, Choi L, Alosh B, Ali-Fehmi R, Mittal S.

Oncotarget. 2015 Jun 10;6(16):14614-24.

28.

Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.

Al-Wahab Z, Mert I, Tebbe C, Chhina J, Hijaz M, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R.

Oncotarget. 2015 May 10;6(13):10908-23.

29.

PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.

Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, Ali-Fehmi R, Coleman RL, Sood AK.

Mol Cancer Ther. 2015 Jun;14(6):1466-1475. doi: 10.1158/1535-7163.MCT-14-1077. Epub 2015 Apr 1.

30.

Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance.

Roma AA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R, Rutgers JK, Barbuto D, Silva EG.

Am J Surg Pathol. 2015 May;39(5):667-72. doi: 10.1097/PAS.0000000000000402.

PMID:
25724003
31.

The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study.

Winer I, Alvarado-Cabrero I, Hassan O, Ahmed QF, Alosh B, Bandyopadhyay S, Thomas S, Albayrak S, Talukdar S, Al-Wahab Z, Elshaikh MA, Munkarah A, Morris R, Ali-Fehmi R.

Gynecol Oncol. 2015 Jun;137(3):474-8. doi: 10.1016/j.ygyno.2015.02.005. Epub 2015 Feb 10.

PMID:
25677061
32.

Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.

Mahdi H, Elshaikh MA, DeBenardo R, Munkarah A, Isrow D, Singh S, Waggoner S, Ali-Fehmi R, Morris RT, Harding J, Moslemi-Kebria M.

Gynecol Oncol. 2015 May;137(2):239-44. doi: 10.1016/j.ygyno.2015.01.544. Epub 2015 Jan 29.

PMID:
25641568
33.

Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.

Mahdi H, Rose PG, Elshaikh MA, Munkarah A, Isrow D, Singh S, Waggoner S, Ali-Fehmi R, Morris RT, Harding J, DeBenardo R.

Gynecol Oncol. 2015 Mar;136(3):529-33. doi: 10.1016/j.ygyno.2014.12.034. Epub 2015 Jan 7.

PMID:
25575483
34.

Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.

Mahdi H, Munkarah AR, Ali-Fehmi R, Woessner J, Shah SN, Moslemi-Kebria M.

Arch Gynecol Obstet. 2015 Jul;292(1):183-90. doi: 10.1007/s00404-014-3609-6. Epub 2014 Dec 31.

PMID:
25549769
35.

Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.

Ahmed QF, Gattoc L, Al-Wahab Z, Abdulfatah E, Ruterbusch JJ, Cote M, Bandyopadhyay S, Morris RT, Ali-Fehmi R.

Am J Surg Pathol. 2015 Feb;39(2):221-6. doi: 10.1097/PAS.0000000000000361.

PMID:
25517962
36.

Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.

Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, Ali-Fehmi R, Rose PG, Munkarah AR.

Gynecol Oncol. 2015 Feb;136(2):235-9. doi: 10.1016/j.ygyno.2014.12.012. Epub 2014 Dec 12.

PMID:
25511158
37.

Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?

Winer I, Ahmed QF, Mert I, Bandyopadhyay S, Cote M, Munkarah AR, Hussein Y, Al-Wahab Z, Elshaikh MA, Alosh B, Schultz DS, Mahdi H, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R.

Int J Gynecol Pathol. 2015 Jan;34(1):47-56. doi: 10.1097/PGP.0000000000000113.

PMID:
25473753
38.

Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML.

Breast J. 2014 Nov-Dec;20(6):571-7. doi: 10.1111/tbj.12331. Epub 2014 Sep 8.

39.

Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.

Ahmad A, Sethi S, Chen W, Ali-Fehmi R, Mittal S, Sarkar FH.

Am J Transl Res. 2014 Jul 18;6(4):384-90. eCollection 2014.

40.

Dietary energy balance modulates ovarian cancer progression and metastasis.

Al-Wahab Z, Tebbe C, Chhina J, Dar SA, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R.

Oncotarget. 2014 Aug 15;5(15):6063-75.

41.

The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036. Epub 2014 Jun 19.

42.

Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites.

Moschiano EJ, Barbuto DA, Walsh C, Singh K, Euscher ED, Roma AA, Ali-Fehmi R, Frauenhoffer EE, Montiel DP, Kim I, Djordjevic B, Malpica A, Hong SR, Silva EG.

Int J Gynecol Pathol. 2014 May;33(3):268-73. doi: 10.1097/PGP.0b013e31829c6757.

PMID:
24681738
43.

Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Cote ML, Ruterbusch JJ, Ahmed Q, Bandyopadhyay S, Alosh B, Abdulfatah E, Seward S, Morris R, Ali-Fehmi R.

Gynecol Oncol. 2014 Apr;133(1):38-42. doi: 10.1016/j.ygyno.2014.01.013.

44.

Racial disparities in uterine clear cell carcinoma: a multi-institution study.

Al-Wahab ZR, Kumar S, Mutch DG, Dowdy SC, Hensley SA, Wang Y, Mahdi H, Ali-Fehmi R, Morris RT, Elshaikh M, Munkarah AR.

Int J Gynecol Cancer. 2014 Mar;24(3):541-8. doi: 10.1097/IGC.0000000000000068.

PMID:
24552897
45.

Gynecologic cancers: molecular updates.

Ahmed Q, Alosh B, Bandyopadhyay S, Ali-Fehmi R.

Clin Lab Med. 2013 Dec;33(4):911-25. doi: 10.1016/j.cll.2013.09.001. Review.

PMID:
24267195
46.

Breast carcinoma: molecular profiling and updates.

Bandyopadhyay S, Ali-Fehmi R.

Clin Lab Med. 2013 Dec;33(4):891-909. doi: 10.1016/j.cll.2013.08.009. Review.

PMID:
24267194
47.

Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.

Ahmed Q, Hussein Y, Hayek K, Bandyopadhyay S, Semaan A, Abdul-Karim F, Al-Wahab Z, Munkarah AR, Elshaikh MA, Alosh B, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R.

Gynecol Oncol. 2014 Feb;132(2):372-6. doi: 10.1016/j.ygyno.2013.11.011. Epub 2013 Nov 19.

PMID:
24262874
48.

Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer.

Jiron J, Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Kato I.

Am J Otolaryngol. 2014 Mar-Apr;35(2):147-53. doi: 10.1016/j.amjoto.2013.09.004. Epub 2013 Sep 28.

49.

Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma.

Matsuo K, Nishimura M, Komurov K, Shahzad MM, Ali-Fehmi R, Roh JW, Lu C, Cody DD, Ram PT, Loizos N, Coleman RL, Sood AK.

Gynecol Oncol. 2014 Jan;132(1):166-75. doi: 10.1016/j.ygyno.2013.10.027. Epub 2013 Oct 29.

50.

Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study.

Diaz De Vivar A, Roma AA, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Arville B, Teramoto N, Ali-Fehmi R, Rutgers JK, Tabassum F, Barbuto D, Aguilera-Barrantes I, Shaye-Brown A, Daya D, Silva EG.

Int J Gynecol Pathol. 2013 Nov;32(6):592-601. doi: 10.1097/PGP.0b013e31829952c6.

PMID:
24071876

Supplemental Content

Loading ...
Support Center